FibroGen
FGEN
₹22.65
Share price
4.24%
Change (1 day)
-81.98%
Change (1 year)
Categories
Revenue for FibroGen (FGEN)
Revenue in 2024 (TTM): ₹2.18 Billion
According to FibroGen's latest financial reports the company's current revenue (TTM 
) is ₹2.55 Billion. a decrease over the revenue in the year 2023 that were of ₹12.30 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for FibroGen from 2014 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | ₹2.54 B | -79.34% |
| 2023 | ₹12.30 B | 5.62% |
| 2022 | ₹11.64 B | -33.51% |
| 2021 | ₹17.51 B | 35.82% |
| 2020 | ₹12.89 B | -29.52% |
| 2019 | ₹18.29 B | 22.87% |
| 2018 | ₹14.89 B | 63.35% |
| 2017 | ₹9.11 B | -25.3% |
| 2016 | ₹12.20 B | 1.55% |
| 2015 | ₹12.01 B | 37.79% |
| 2014 | ₹8.72 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 | ₹376.65 B | 14,660.30% | 🇺🇸 USA |
 | ₹9.71 B | 280.70% | 🇺🇸 USA |
 | ₹1.00 B | -60.51% | 🇺🇸 USA |